TG Therapeutics (NKB2.STU) Q2 2026 Earnings

11MayConfirmed
Q1 2026
Next
0.12
0.18
0.24
0.3

Details

Expected EPS
0.2319598014
Actual EPS
N/A
Surprise EPS
-0.23
Surprise Percent
+100%

Description

TG Therapeutics (NKB2.STU) will report earnings of for Q2 2026 on May 11, 2026.

0 Comments

Share your thoughts